First Trust Direct Indexing’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-1,257
Closed -$260K – 987
2024
Q2
$260K Buy
1,257
+478
+61% +$108K 0.02% 721
2024
Q1
$211K Buy
+779
New +$186K 0.02% 713

Other funds holding CRL

First Trust Direct Indexing's CRL Position: Q3 2024 in Review

First Trust Direct Indexing sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 1,257 shares — an estimated $260K sold.

First Trust Direct Indexing first reported a position in CRL in Q1 2024 and held it in 2 quarters. The position peaked at $260K in Q2 2024. 631 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • First Trust Direct Indexing reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 1,257 Charles River Laboratories shares in Q3 2024, an estimated $260K.
  • First Trust Direct Indexing first reported a position in Charles River Laboratories in Q1 2024 and held it in 2 quarters.
  • First Trust Direct Indexing's Charles River Laboratories position peaked at $260K in Q2 2024.
  • 631 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on First Trust Direct Indexing's 13F filing for Q3 2024, filed 25 Oct 2024.